My Cart

GDF-2

GDF-2 Overview

English NameGrowth/differentiation factor 2Approved Drugs0
Drugs in Clinical Trials1Target SynonymGDF-2,BMP-9,BMP9,HHT5,Bone Morphogenetic Protein 9
Highest Development StagePhase 2 Clinical
English NameGrowth/differentiation factor 2
Target SynonymGDF-2,BMP-9,BMP9,HHT5,Bone Morphogenetic Protein 9
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

GDF-2 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Tag Free (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
GD2-H5211
Human
HEK293
Human GDF-2 Protein, Tag Free
Add to Cart
Total: 1
  • 1

GDF-2 Background

Human Growth and differentiation factor 2 (GDF-2), also known as Bone morphogenetic protein 9 (BMP-9), is a member of the BMP subgroup of the TGF-beta superfamily proteins that signal through heterodimeric complexes composed of type I and type II BMP receptors. GDF-2 Potent circulating inhibitor of angiogenesis. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG. ALK1 is a signalling receptor for bone morphogenetic protein-9 (BMP-9) in endothelial cells (ECs). BMP-9 bound with high affinity to ALK1 and endoglin, and weakly to the type-I receptor ALK2 and to the BMP type-II receptor (BMPR-II) and activin type-II receptor (ActR-II) in transfected COS cells. Binding of BMP-9 to ALK2 was greatly facilitated when BMPR-II or ActR-II were co-expressed.

GDF-2 Synonyms

GDF-2,GDF2,BMP-9,BMP9

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
PF-07868489PF-07868489Phase 2 ClinicalPfizer IncHypertension, Pulmonary; Pulmonary Arterial Hypertension
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland